Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 6/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.31 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.31 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.30 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24920730 | 0.89 | NPC1 (0.35) | NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL24920863 | 0.83 | NPC1 (0.37) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD | |
| SCHEMBL24921639 | 0.81 | NPC1 (0.38) | NPC1RAB9ASMN1; SMN2HPGD | |
| SCHEMBL24920909 | 0.80 | NPC1 (0.38) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD | |
| SCHEMBL24920888 | 0.80 | NPC1 (0.36) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD | |
| SCHEMBL24921215 | 0.80 | NPC1 (0.40) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD | |
| SCHEMBL24920850 | 0.80 | ALOX5AP (0.35) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD | |
| SCHEMBL24920854 | 0.80 | ALOX5AP (0.34) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD | |
| SCHEMBL24920861 | 0.78 | NPC1 (0.38) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD | |
| SCHEMBL24921252 | 0.77 | NPC1 (0.39) | NPC1RAB9ASMN1; SMN2ALOX5APHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023006097-A1 | BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER | 海创药业股份有限公司 | 2023-02-02 | — | — | WO | disclosed |